Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 67, pseudogene (RN7SL67P) is a non-coding RNA pseudogene that shares homology with functional 7SL RNA genes, which normally serve as the RNA component of the signal recognition particle (SRP) involved in cotranslational targeting of secretory proteins to the endoplasmic reticulum[1][6][5]. As a pseudogene, RN7SL67P does not encode a functional RNA or protein, and is generally considered to be transcriptionally inactive, though some pseudogenes can be transcribed or influence gene regulation via formation of small interfering RNAs or acting as microRNA decoys[4][5]. There is currently no evidence indicating RN7SL67P is a therapeutic target, disease biomarker, or drug-interacting molecule. Its primary classification is as a non-coding RNA pseudogene, and though pseudogenes can occasionally have regulatory effects in health and disease, no such functions have been directly attributed to RN7SL67P. Key points: - RN7SL67P is not a protein, receptor, enzyme, or standard therapeutic target[1][6]. - Closely related functional RNAs (such as 7SL RNA) are essential, but RN7SL67P itself lacks a demonstrated biological function[1][6][5]. - The naming and provided information are correct and correspond to a genuine human gene annotation[1][6]. If you require detailed information about the functional 7SL RNA (SRP RNA), which has architectural and regulatory roles in the signal recognition particle, let me know. However, RN7SL67P specifically is a pseudogene and not an active molecular or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 67, pseudogene (RN7SL67P).